Neovasc Investor Relations Material
Latest events
Q3 2022
Neovasc
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Neovasc Inc
Access all reports
Neovasc Inc. is a specialty medical device company, developing, manufacturing and marketing products for the cardiovascular marketplace worldwide. The company's focus is on the development of products that are intended to replace or repair cardiac valves. The Company plans to continue strengthening its commercial infrastructure to support its sales effort for TIARA, an important product for the company, including expanding their sales force across Europe and globally.
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇨🇦 Canada